Cell-Free DNA Testing for Fetal Chromosomal Anomalies in clinical practice: Austrian-German-Swiss Recommendations for non-invasive prenatal tests (NIPT)

Key words

chromosomal aberration - Down syndrome - genetic defects - laboratory tests - ultrasound

• References

• 1 Rossi AC, Prefumo F. Accuracy of ultrasonography at 11-14 weeks of gestation for detection of fetal structural anomalies: a systematic review. Obstet Gynecol 2013; 122: 1160-1167
• 2 Salomon LJ, Alfirevic Z, Audibert F et al. ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice. Z Geburtshilfe Neonatol 2014; 218: 242-243
• 3 Willems PJ, Dierickx H, Vandenakker E et al. The first 3,000 Non-Invasive Prenatal Tests (NIPT) with the Harmony test in Belgium and the Netherlands. Facts Views Vis Obgyn 2014; 6: 7-12
• 4 Eiben B, Krapp M, Borth H et al. Single‒Nucleotide-Polymorphism-based Analysis of Cell-Free fetal DNA in 3000 cases from Germany and Austria. Ultrasound International Open 2015; 01: E8-E11
• 5 Wang E, Batey A, Struble C et al. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn 2013; 33: 662-666
• 6 Mao J, Wang T, Wang BJ et al. Confined placental origin of the circulating cell free fetal DNA revealed by a discordant non-invasive prenatal test result in a trisomy 18 pregnancy. Clin Chim Acta 2014; 433: 190-193
• 7 Curnow KJ, Wilkins-Haug L, Ryan A et al. Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test. Am J Obstet Gynecol 2015; 212: 79
• 8 Gregg AR, Gross SJ, Best RG et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013; 15: 395-398
• 9 American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012; 120: 1532-1534
• 10 Devers PL, Cronister A, Ormond KE et al. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Couns 2013; 22: 291-295
• 11 Benn P, Borell A, Chiu R et al. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2013; 33: 622-629
• 12 Merz E, Thode C, Eiben B et al. Individualized correction for maternal weight in calculating the risk of chromosomal abnormalities with first-trimester screening data. Ultraschall in Med 2011; 32: 33-39
• 13 Eiben B, Thode C, Merz E. Nichtinvasive Pränataldiagnostik-Serumtestsyteme zur Erfassung von Chromosomenanomalien. Gynäkologie + Geburtshilfe 2013; 18: 2-4
• 14 Kagan KO, Wright D, Nicolaides KH. First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2015; 45: 42-47
• 15 Nicolaides KH, Syngelaki A, Poon LC et al. First-trimester contingent creening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing. Fetal Diagn Ther 2014; 35: 185-192
• 16 Stellungnahme der Deutschen Gesellschaft für Humangenetik (GfH) zur Analyse fetaler DNA aus dem mütterlichen Blut. http://www.gfhev.de/de/leitlinien/LL_und_Stellungnahmen/2012_11_12_GfH_Stellungnahme_Analyse_fetale_DNA.pdf
• 17 Kagan KO, Hoopmann M, Hammer R et al. Screening auf Chromosomenstörungen mittels Ersttrimester-Screening und non-invasive prenatal Testing. Ultraschall in Med 2015; 36: 40-46
• 18 Gil MM, Quezada MS, Bregant B et al. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. Ultrasound Obstet Gynecol 2013; 42: 34-40
• 19 Lund IC, Christensen R, Petersen OB et al. Chromosomal microarray in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 2015; 45: 95-100
• 20 Bianchi DW, Parker RL, Wentworth J et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 370: 799-808
• 21 Norton ME, Jacobsson B, Swamy GK et al. Cell-free DNA Analysis for Noninvasive Examination of Trisomy. N Engl J Med 2015;
• 22 Gil MM, Quezada MS, Revello R et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015;
• 23 Kalousek DK, Barrett IJ, McGillivray BC. Placental mosaicism and intrauterine vival of trisomies 13 and 18. Am J Hum Genet 1989; 44: 338-343
• 24 Wapner RJ, Babiarz JE, Levy B et al. Expanding the scope of noninvasive prenatal testing:detection of fetal microdeletion syndromes. Am J Obstet Gynecol 2014; pii:S0002-9378(14)02374-6
• 25 Eiben B, Glaubitz R, Kagan KO. Nichtinvasive Pränataldiagnostik. ETS und NGS-basierte Tests. Medgen Springer-Verlag; 2014
• 26 Chitty LS, Khalil A, Barrett AN et al. Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA. Prenat Diagn 2013; 33: 416-423